Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway

Fig. 2

The potential of cell-free DNA for noninvasive cancer management Plasma cell-free circulating tumor DNA (ctDNA) analysis shows promises for noninvasive molecular stratification, monitoring treatment responses and identifying genetic mechanisms of resistance to guide optimal treatment strategies

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us